Hedgehog signaling in lung cancer: from oncogenesis to cancer treatment resistance

E Giroux-Leprieur, A Costantini, VW Ding… - International journal of …, 2018 - mdpi.com
Hedgehog signaling pathway is physiologically activated during embryogenesis, especially
in lung development. It is also reactivated in many solid tumors. In lung cancer, Hedgehog …

Role of GLI transcription factors in pathogenesis and their potential as new therapeutic targets

M Sabol, D Trnski, V Musani, P Ozretić… - International journal of …, 2018 - mdpi.com
GLI transcription factors have important roles in intracellular signaling cascade, acting as the
main mediators of the HH-GLI signaling pathway. This is one of the major developmental …

Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma

S Song, Q Chen, Y Li, G Lei, A Scott, L Huo, CY Li… - Gut, 2021 - gut.bmj.com
Objective Gastro-oesophageal cancers (GEC) are resistant to therapy and lead to poor
prognosis. The cancer stem cells (CSCs) and antiapoptotic pathways often confer therapy …

YAP1-mediated CDK6 activation confers radiation resistance in esophageal cancer–Rationale for the combination of YAP1 and CDK4/6 inhibitors in esophageal …

F Li, Y Xu, B Liu, PK Singh, W Zhao, J Jin, G Han… - Clinical Cancer …, 2019 - AACR
Purpose: Esophageal cancer is a lethal disease that is often resistant to therapy. Alterations
of YAP1 and CDK6 are frequent in esophageal cancer. Deregulation of both molecules may …

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma

S Song, Y Li, Y Xu, L Ma, M Pool Pizzi, J Jin… - Molecular …, 2020 - Wiley Online Library
Hippo/YAP1 signaling is a major regulator of organ size, cancer stemness, and aggressive
phenotype. Thus, targeting YAP1 may provide a novel therapeutic strategy for tumors with …

Linking cancer stem cell plasticity to therapeutic resistance-mechanism and novel therapeutic strategies in esophageal cancer

C Zhou, N Fan, F Liu, N Fang, PS Plum, R Thieme… - Cells, 2020 - mdpi.com
Esophageal cancer (EC) is an aggressive form of cancer, including squamous cell
carcinoma (ESCC) and adenocarcinoma (EAC) as two predominant histological subtypes …

GANT61 and lithium chloride inhibit the growth of head and neck cancer cell lines through the regulation of GLI3 processing by GSK3β

V Zubčić, N Rinčić, M Kurtović, D Trnski… - International journal of …, 2020 - mdpi.com
Several signaling pathways are aberrantly activated in head and neck squamous cell
carcinoma (HNSCC), including the Hedgehog-Gli (HH-GLI), WNT, EGFR, and NOTCH …

Therapeutic strategies against cancer stem cells in esophageal carcinomas

PK Das, F Islam, RA Smith, AK Lam - Frontiers in Oncology, 2021 - frontiersin.org
Cancer stem cells (CSCs) in esophageal cancer have a key role in tumor initiation,
progression and therapy resistance. Novel therapeutic strategies to target CSCs are being …

Cancer stem cells in esophageal squamous cell carcinoma

G Sun, Y Yang, J Liu, Z Gao, T Xu, J Chai, J Xu… - … -Research and Practice, 2022 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is one of the most intractable challenges
among human diseases with poor prognosis and shortness of effective therapeutic options …

Biomarkers for the prediction of esophageal cancer neoadjuvant chemoradiotherapy response: A systemic review

Y Li, J Liu, X Cai, H Li, Y Cheng, X Dong, W Yu… - Critical Reviews in …, 2021 - Elsevier
Neoadjuvant chemoradiotherapy followed by surgery has been established as the standard
treatment for locally advanced esophageal cancer. For patients with complete regression …